We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Lactose Intolerance Following Stem Cell Transplantation

This study has been terminated.
(Too few patients completed the study once enrolled.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00247806
First Posted: November 2, 2005
Last Update Posted: September 25, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of British Columbia
October 31, 2005
November 2, 2005
September 25, 2008
October 2008
December 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00247806 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence of Lactose Intolerance Following Stem Cell Transplantation
Prevalence of Lactose Intolerance Following Stem Cell Transplantation in Pediatric Patients.
It is currently assumed that all patients are lactose intolerant post bone marrow transplantation. This pilot study is to assess what the incidence of lactose intolerance is after bone marrow transplantation in children. This will be done using a lactose breath test.
All pediatric patients over the age of 4 years who are scheduled for a stem cell transplant will be approached to assess whether what the incidence of lactose intolerance is in the post transplant period and how quickly recovery occurs. A baseline lactose and lactulose breath test will be performed followed by repeat lactose breath tests starting 2 weeks after day 0 and repeated every fortnight for 10 weeks. Stool pH and reducing substances will be checked at the time of the breath tests to see if there is any correlation.
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Lactose Intolerance
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
20
December 2010
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients planned to undergo a stem cell transplant.

Exclusion Criteria:

  • Refusal to participate
  • Unable to perform breath tests on request (generally under the age of 4 years.)
Sexes Eligible for Study: All
4 Years to 18 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00247806
C05-0180
Not Provided
Not Provided
Not Provided
Dr. Colin C Barker, University of British Columbia
University of British Columbia
Not Provided
Principal Investigator: Colin Barker, PhD University of British Columbia
University of British Columbia
October 2005
To Top